drugset / Trial / NCT01049646

Interaction of Apelin and Angiotensin in the Systemic Circulation

NCT01049646

Completed 12 enrolled University of Edinburgh
RandomizedCrossoverDouble-blindBasic science

Summary

The apelin-APJ system is a relatively new discovery. It has generated interest in part due to it's apparent ability to counteract the renin-angiotensin system, which is frequently overactive in many cardiovascular disease. Apelin improves that pumping ability of the heart and we wish to know if this action persists in the presence of increased levels of angiotensin II.

Timeline

Start
2010-01
Primary completion
2010-04
Completion
2010-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Angiotensin II Peptide 0.5 ug/kg

Indications

No indication recorded.